High-altitude exposure in patients with cardiovascular disease: Risk assessment and practical recommendations

Progress in Cardiovascular Diseases

Volumn 52, Issue 6, 2010, Pages 512-524

  Rimoldi, Stefano F ^a   Sartori, Claudio ^b   Seiler, Christian ^a   Delacrétaz, Etienne ^a   Mattle, Heinrich P ^c   Scherrer, Urs ^b   Allemann, Yves ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Neurologische Universitatsklinik Bern   (Switzerland)

Author keywords

Altitude induced hypoxemia; Barometric pressure; Cardiovascular disease; Cardiovascular risk assessment; High altitude exposure

Indexed keywords

ALTITUDE; ALTITUDE ACCLIMATIZATION; ARTICLE; CARDIOVASCULAR DISEASE; COLD; ENVIRONMENTAL FACTOR; EXERCISE; EXPOSURE; HUMAN; HUMIDITY; PATIENT COUNSELING; PHYSIOLOGICAL PROCESS; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK REDUCTION; STRESS; TISSUE OXYGENATION; TRAVEL;

ACCLIMATIZATION; ALTITUDE; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CORONARY ARTERY DISEASE; FORAMEN OVALE, PATENT; HEART DEFECTS, CONGENITAL; HEART FAILURE; HEART VALVE DISEASES; HUMANS; HYPERTENSION; MOUNTAINEERING; PULMONARY CIRCULATION; RISK ASSESSMENT; RISK FACTORS;

EID: 77952127474     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2010.03.005     Document Type: Article

References (62)

1. Duplain H., Vollenweider L., Delabays A., et al. Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema. Circulation 1999, 99:1713-1718.
2. Hainsworth R., Drinkhill M.J. Cardiovascular adjustments for life at high altitude. Respir Physiol Neurobiol 2007, 158:204-211.
3. Hansen J., Sander M. Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia. J Physiol 2003, 546:921-929.
4. Huez S., Faoro V., Guenard H., et al. Echocardiographic and tissue Doppler imaging of cardiac adaptation to high altitude in native highlanders versus acclimatized lowlanders. Am J Cardiol 2009, 103:1605-1609.
5. Klausen K. Cardiac output in man in rest and work during and after acclimatization to 3,800 m. J Appl Physiol 1966, 21:609-616.
6. Vogel J.A., Harris C.W. Cardiopulmonary responses of resting man during early exposure to high altitude. J Appl Physiol 1967, 22:1124-1128.
7. Allemann Y., Rotter M., Hutter D., et al. Impact of acute hypoxic pulmonary hypertension on LV diastolic function in healthy mountaineers at high altitude. Am J Physiol Heart Circ Physiol 2004, 286:H856-H862.
8. Tune J.D. Control of coronary blood flow during hypoxemia. Adv Exp Med Biol 2007, 618:25-39.
9. Mazzeo R.S., Reeves J.T. Adrenergic contribution during acclimatization to high altitude: perspectives from Pikes Peak. Exerc Sport Sci Rev 2003, 31:13-18.
10. Palatini P., Businaro R., Berton G., et al. Effects of low altitude exposure on 24-hour blood pressure and adrenergic activity. Am J Cardiol 1989, 64:1379-1382.
11. Savonitto S., Cardellino G., Doveri G., et al. Effects of acute exposure to altitude (3,460 m) on blood pressure response to dynamic and isometric exercise in men with systemic hypertension. Am J Cardiol 1992, 70:1493-1497.
12. Roach R.C., Houston C.S., Honigman B., et al. How well do older persons tolerate moderate altitude?. West J Med 1995, 162:32-36.
13. Wu T.Y., Ding S.Q., Liu J.L., et al. Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad. High Alt Med Biol 2007, 8:88-107.
14. Sartori C., Allemann Y., Duplain H., et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002, 346:1631-1636.
15. Scherrer U., Vollenweider L., Delabays A., et al. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 1996, 334:624-629.
16. Bartsch P., Gibbs J.S. Effect of altitude on the heart and the lungs. Circulation 2007, 116:2191-2202.
17. Ainslie P.N., Ogoh S. Regulation of cerebral blood flow in mammals during chronic hypoxia: a matter of balance. Exp Physiol 2010, 95:251-262.
18. Allemann Y., Hutter D., Lipp E., et al. Patent foramen ovale and high-altitude pulmonary edema. JAMA 2006, 296:2954-2958.
19. Gordon J.B., Ganz P., Nabel E.G., et al. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest 1989, 83:1946-1952.
20. Yasue H., Nagao M., Omote S., et al. Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion. Circulation 1978, 58:56-62.
21. Seiler C. The collateral circulation of the heart 2009, Springer, London.
22. Erdmann J., Sun K.T., Masar P., et al. Effects of exposure to altitude on men with coronary artery disease and impaired left ventricular function. Am J Cardiol 1998, 81:266-270.
23. Grover R.F., Tucker C.E., McGroarty S.R., et al. The coronary stress of skiing at high altitude. Arch Intern Med 1990, 150:1205-1208.
24. Levine B.D., Zuckerman J.H., deFilippi C.R. Effect of high-altitude exposure in the elderly: the Tenth Mountain Division study. Circulation 1997, 96:1224-1232.
25. Morgan B.J., Alexander J.K., Nicoli S.A., et al. The patient with coronary heart disease at altitude: observations during acute exposure to 3100 meters. J Wilderness Med 1990, 1:147-153.
26. Okin J.T. Response of patients with coronary heart disease to exercise at varying altitudes. Adv Cardiol 1970, 5:92-96.
27. Schmid J.P., Noveanu M., Gaillet R., et al. Safety and exercise tolerance of acute high altitude exposure (3454 m) among patients with coronary artery disease. Heart 2006, 92:921-925.
28. Yaron M., Hultgren H.N., Alexander J.K. Low risk of myocardial ischemia in the elderly visiting moderate altitude. Wilderness Environ Med 1995, 6:20-28.
29. Silverman D., Gendreau M. Medical issues associated with commercial flights. Lancet 2009, 373:2067-2077.
30. Faeh D., Gutzwiller F., Bopp M. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation 2009, 120:495-501.
31. Agostoni P., Cattadori G., Guazzi M., et al. Effects of simulated altitude-induced hypoxia on exercise capacity in patients with chronic heart failure. Am J Med 2000, 109:450-455.
32. Mahmud E., Raisinghani A., Hassankhani A., et al. Correlation of left ventricular diastolic filling characteristics with right ventricular overload and pulmonary artery pressure in chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2002, 40:318-324.
33. Nault P., Halman S., Paradis J. Ankle-brachial index on Kilimanjaro: lessons from high altitude. Wilderness Environ Med 2009, 20:72-76.
34. Ponchia A., Noventa D., Bertaglia M., et al. Cardiovascular neural regulation during and after prolonged high altitude exposure. Eur Heart J 1994, 15:1463-1469.
35. Burtscher M. Risk of cardiovascular events during mountain activities. Adv Exp Med Biol 2007, 618:1-11.
36. Groves B.M., Reeves J.T., Sutton J.R., et al. Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol 1987, 63:521-530.
37. Galie N., Hoeper M.M., Humbert M., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009, 30:2493-2537.
38. Sartori C., Allemann Y., Scherrer U. Pathogenesis of pulmonary edema: learning from high-altitude pulmonary edema. Respir Physiol Neurobiol 2007, 159:338-349.
39. Hackett P.H., Creagh C.E., Grover R.F., et al. High-altitude pulmonary edema in persons without the right pulmonary artery. N Engl J Med 1980, 302:1070-1073.
40. Naeije R., De Backer D., Vachiery J.L., et al. High-altitude pulmonary edema with primary pulmonary hypertension. Chest 1996, 110:286-289.
41. Swenson E.R. Renal function and fluid homeostasis. High altitude: an exploration of human adaptation 2001, 525-568. Marcel Dekker, New York. T.F. Hornbein, R.B. Schoene (Eds.).
42. Reinhart W.H., Kayser B., Singh A., et al. Blood rheology in acute mountain sickness and high-altitude pulmonary edema. J Appl Physiol 1991, 71:934-938.
43. Pichler Hefti J., Risch L., Hefti U., et al. Changes of coagulation parameters during high altitude expedition. Swiss Med Wkly 2010, 140:111-117.
44. Kerut E.K., Norfleet W.T., Plotnick G.D., et al. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001, 38:613-623.
45. Torti S.R., Billinger M., Schwerzmann M., et al. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J 2004, 25:1014-1020.
46. Benumof J.L., Pirlo A.F., Johanson I., et al. Interaction of PVO2 with PAO2 on hypoxic pulmonary vasoconstriction. J Appl Physiol 1981, 51:871-874.
47. Das B.B., Wolfe R.R., Chan K.C., et al. High-altitude pulmonary edema in children with underlying cardiopulmonary disorders and pulmonary hypertension living at altitude. Arch Pediatr Adolesc Med 2004, 158:1170-1176.
48. Harinck E., Hutter P.A., Hoorntje T.M., et al. Air travel and adults with cyanotic congenital heart disease. Circulation 1996, 93:272-276.
49. Burtscher M., Mittleman M.A. Time-dependent SCD risk during mountain sports changes with age. Circulation 1995, 92:3151-3152.
50. Burtscher M., Philadelphy M., Nachbauer W., et al. The risk of death to trekkers and hikers in the mountains. Jama 1995, 273:460.
51. Burtscher M., Pachinger O., Mittleman M.A., et al. Prior myocardial infarction is the major risk factor associated with sudden cardiac death during downhill skiing. Int J Sports Med 2000, 21:613-615.
52. Gibelli G., Fantoni C., Anza C., et al. Arrhythmic risk evaluation during exercise at high altitude in healthy subjects: role of microvolt T-wave alternans. Pacing Clin Electrophysiol 2008, 31:1277-1283.
53. Kujanik S., Snincak M., Vokal J., et al. Periodicity of arrhythmias in healthy elderly men at the moderate altitude. Physiol Res 2000, 49:285-287.
54. Weilenmann D., Duru F., Schonbeck M., et al. Influence of acute exposure to high altitude and hypoxemia on ventricular stimulation thresholds in pacemaker patients. Pacing Clin Electrophysiol 2000, 23:512-515.
55. Anand A.C., Jha S.K., Saha A., et al. Thrombosis as a complication of extended stay at high altitude. Natl Med J India 2001, 14:197-201.
56. Jha S.K., Anand A.C., Sharma V., et al. Stroke at high altitude: Indian experience. High Alt Med Biol 2002, 3:21-27.
57. Baumgartner R.W., Siegel A.M., Hackett P.H. Going high with preexisting neurological conditions. High Alt Med Biol 2007, 8:108-116.
58. Cheng S., Chng S.M., Singh R. Cerebral venous infarction during a high altitude expedition. Singapore Med J 2009, 50:e306-e308.
59. Agostoni P., Contini M., Magini A., et al. Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia. Eur J Heart Fail 2006, 8:729-735.
60. Mancia G., De Backer G., Dominiczak A., et al. Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
61. Swenson E.R. ACE inhibitors and high altitude. High Alt Med Biol 2004, 5:92-94.
62. Pratt M.C., Lewis-Barned N.J., Walker R.J., et al. Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Clin Pharmacol 1992, 34:363-365.